BLU-945

N/A

Report date: 2025/02/12 20:00:40
NME

Base Information

Drug NameBLU-945
Drug Alias NameBLU-945ZL-2313
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEGFR T790M inhibitorsEGFR C797S inhibitors
TargetsEGFR T790MEGFR C797S
Therapy Area/IndicationsLung DiseasesRespiratory Tract DiseasesCarcinoma, Non-Small-Cell Lung +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSingapore +[12] 
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesBlueprint Medicines Corp
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZai Lab (Shanghai) Co LtdBlueprint Medicines Corp
Inactive CompaniesPatheon Development Services Inc
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsLung DiseasesRespiratory Tract DiseasesCarcinoma, Bronchogenic +[11] 

Other Information

ATC CodeN/A
Related LinksN/A